Aspira Women's Health Investor Relations Material
Latest events
Q3 2024
Aspira Women's Health
Q1 2025
19 May, 2025
Q4 2024
27 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Aspira Women's Health Inc
Access all reports
Aspira Women’s Health Inc. is a healthcare company focused on developing and commercializing diagnostic tools for women’s health, particularly in the areas of gynecologic disease and oncology. The company’s flagship products include advanced blood-based biomarker tests, such as those designed to assess ovarian cancer risk and improve early detection. Aspira Women’s Health is headquartered in Austin, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
AWH
Country
🇺🇸 United States